Work

Abstract PS3-11-28: EmpowHER-208: A phase 2 neoadjuvant study of zanidatamab in combination with chemotherapy in patients with stage II-III HER2-positive early breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-11-28

Authors: A. G. Waks, S. Hurvitz, E. Hamilton, J. O’Shaughnessy, V. Valero, A. Combest, B. Salim, F. Herbst, S. Faderl, S. M. Tolaney

Institutions: Dana-Farber Cancer Institute, Fred Hutch Cancer Center, Sarah Cannon, Baylor University Medical Center, The University of Texas MD Anderson Cancer Center, Jazz Pharmaceuticals (United States)

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130694640

Cites:

Cited by:

Related to: